Skip to content

SANAS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

SANAS

BE 0427.676.859
NACE 21.209, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€69,601
2024 · -€130,815+€61,214
Equity
€362,620
2024 · €432,221-€69,601
Cash
€50,454
2024 · €213,305-€162,851
Balance sheet total
€698,330
2024 · €550,328+€148,002

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€208,415

    up €208,415 (+550%), from €37,888 to €246,303

    of which Trade receivables: +€205,346

  • Cash -€162,851

    down €162,851 (-76.3%), from €213,305 to €50,454

    mainly Receivables within one year (-€208,415) and Stocks and contracts (-€137,231)

  • Stocks and contracts +€137,231

    up €137,231 (+91.5%), from €149,994 to €287,226

  • Intangible fixed assets -€24,193

    down €24,193 (-19.9%), from €121,480 to €97,287

Equity and liabilities
  • Trade debts +€159,098

    up €159,098 (+188%), from €84,498 to €243,596

  • Reserves -€70,000

    down €70,000 (-26.7%), from €261,842 to €191,842

    of which Distributable reserves: -€70,000

  • Other debts +€55,544

    up €55,544 (+166%), from €33,469 to €89,014

Income statement
  • Staff costs -€89,376

    down €89,376 (-99.9%), from €89,446 to €70

  • Financial charges -€22,391

    down €22,391 (-60.3%), from €37,108 to €14,718

  • Depreciation -€14,611

    down €14,611 (-30.7%), from €47,591 to €32,980

  • Financial income +€9,492

    up €9,492 (+27,698%), from €34 to €9,526

  • Gross operating margin -€7,316

    down €7,316 (-13.2%), from €55,484 to €48,168

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€130,815
Gross operating margin -€7,316
Staff costs +€89,376
Depreciation +€14,611
Other operating charges +€2,760
Other operating items -€65,485
Financial income +€9,492
Financial charges +€22,391
Taxes -€4,615
Result 2025 -€69,601
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€159,251
Investment -€3,600
Financing €0
Cash 2024 €213,305
Net result for the year -€69,601
Depreciation +€32,980
Stocks and contracts -€137,231
Receivables within one year -€208,415
Deferred charges and accrued income +€5,414
Trade debts +€159,098
Tax, wage and social debts +€2,061
Other debts +€55,544
Accrued charges and deferred income +€900
Investment in fixed assets (net) -€3,600
Cash 2025 €50,454
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €550,328 €698,330 +€148,002 +26.9%
Fixed assets 21/28 €143,543 €114,163 -€29,380 -20.5%
Intangible fixed assets 21 €121,480 €97,287 -€24,193 -19.9%
Tangible fixed assets 22/27 €21,309 €16,122 -€5,187 -24.3%
Plant, machinery and equipment 23 €2,958 €1,977 -€982 -33.2%
Furniture and vehicles 24 €6,618 €3,912 -€2,707 -40.9%
Other tangible fixed assets 26 €11,732 €10,233 -€1,499 -12.8%
Financial fixed assets 28 €755 €755 = 0.0%
Current assets 29/58 €406,785 €584,167 +€177,382 +43.6%
Stocks and contracts in progress 3 €149,994 €287,226 +€137,231 +91.5%
Stocks 30/36 €149,994 €287,226 +€137,231 +91.5%
Amounts receivable within one year 40/41 €37,888 €246,303 +€208,415 +550%
Trade receivables 40 €22,732 €228,079 +€205,346 +903%
Other amounts receivable 41 €15,156 €18,224 +€3,068 +20.2%
Cash at bank and in hand 54/58 €213,305 €50,454 -€162,851 -76.3%
Deferred charges and accrued income 490/1 €5,597 €183 -€5,414 -96.7%
Total equity and liabilities 10/49 €550,328 €698,330 +€148,002 +26.9%
Equity 10/15 €432,221 €362,620 -€69,601 -16.1%
Contributions 10/11 €170,000 €170,000 = 0.0%
Reserves 13 €261,842 €191,842 -€70,000 -26.7%
Non-distributable reserves 130/1 €20,000 €20,000 = 0.0%
Reserves not available under the articles 1311 €20,000 €20,000 = 0.0%
Distributable reserves 133 €241,842 €171,842 -€70,000 -28.9%
Profit (loss) carried forward 14 €379 €778 +€399 +105%
Amounts payable 17/49 €118,107 €335,710 +€217,603 +184%
Amounts payable within one year 42/48 €118,107 €334,810 +€216,703 +183%
Trade debts 44 €84,498 €243,596 +€159,098 +188%
Suppliers 440/4 €84,498 €243,596 +€159,098 +188%
Taxes, remuneration and social security 45 €140 €2,200 +€2,061 +1,476%
Taxes 450/3 €140 €2,200 +€2,061 +1,476%
Remuneration and social security 454/9 €0 - =
Other amounts payable 47/48 €33,469 €89,014 +€55,544 +166%
Accrued charges and deferred income 492/3 - €900 +€900
Remuneration, social security and pensions 62 €89,446 €70 -€89,376 -99.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €47,591 €32,980 -€14,611 -30.7%
Other operating charges 640/8 €7,605 €4,845 -€2,760 -36.3%
Non-recurring operating charges 66A €4,583 €70,068 +€65,485 +1,429%
Gross operating margin 9900 €55,484 €48,168 -€7,316 -13.2%
Operating profit (loss) 9901 -€93,741 -€59,796 +€33,946 +36.2%
Financial income 75/76B €34 €9,526 +€9,492 +27,698%
Recurring financial income 75 €34 €9,526 +€9,492 +27,698%
Financial charges 65/66B €37,108 €14,718 -€22,391 -60.3%
Recurring financial charges 65 €37,108 €14,718 -€22,391 -60.3%
Profit (loss) for the period before taxes 9903 -€130,815 -€64,987 +€65,828 +50.3%
Income taxes 67/77 €0 €4,615 +€4,615
Profit (loss) for the period 9904 -€130,815 -€69,601 +€61,214 +46.8%
Profit (loss) for the period to be appropriated 9905 -€130,815 -€69,601 +€61,214 +46.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.